Amgen (NASDAQ: AMGN) reported Q4 EPS of $4.36, $0.24 better than the analyst estimate of $4.12. Revenue for the quarter came in at $6.85 billion versus the consensus estimate of $6.88 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.